Androgenetic alopecia - New and approved and unapproved treatments

被引:21
作者
Sawaya, ME [1 ]
Shapiro, J [1 ]
机构
[1] Alopecia Res Assoc Technol, Div Clin Res, Ocala, FL USA
关键词
D O I
10.1016/S0733-8635(05)70146-7
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although there are new FDA-approved drug therapies to treat hair loss, there are many unapproved agents with claims of effectively treating hair loss. A variety of new over-the-counter agents are available for consumers to use; however, it is difficult to assess how these agents work, costs of these agents, and efficacy. This article covers the new approved and the large multitude of unapproved treatments that are used to treat hair loss.
引用
收藏
页码:47 / +
页数:16
相关论文
共 52 条
[1]  
Abramowicz M, 1998, MED LETT, V40, P25
[2]  
ANDERSSON S, 1989, J BIOL CHEM, V264, P16249
[3]  
BEERMANN B, 1980, CLIN PHARMACOKINET, V5, P221, DOI 10.2165/00003088-198005030-00003
[4]  
Bramson HN, 1997, J PHARMACOL EXP THER, V282, P1496
[5]   INHIBITION OF ANDROGEN BINDING IN HUMAN FORESKIN FIBROBLASTS BY ANTI-ANDROGENS [J].
BROWN, TR ;
ROTHWELL, SW ;
SULTAN, C ;
MIGEON, CJ .
STEROIDS, 1981, 37 (06) :635-648
[6]  
Carraro JC, 1996, PROSTATE, V29, P231, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt
[7]  
231::AID-PROS4&gt
[8]  
3.0.CO
[9]  
2-E
[10]   THE PSYCHOLOGICAL EFFECTS OF ANDROGENETIC ALOPECIA IN MEN [J].
CASH, TF .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (06) :926-931